Back to first-pass browser

First-pass extracted concept

tumor microenvironment reprogramming

Candidate: concept label3 source documents5 linked claims
Jump to explainersJump to evidenceJump to sourcesJump to claims
Live refresh every 5sNext refresh in 5s

Aliases

regulating the immunosuppressive TME, reprogramming of the TME, TME reprogramming

Extracted Explainers

What the tool is doing

This strategy class aims to reprogram the tumor microenvironment. In the abstract, it is directly linked to overcoming a major barrier in mCRC, namely a highly immunosuppressive microenvironment.

Source 1DOIPubMed

The review identifies reprogramming of the tumor microenvironment as an innovative strategy to improve CAR-T performance in solid tumors.

Source 2DOIPubMed

What problem it solves

It addresses the immunosuppressive state of metastatic colorectal tumors that limits effective immune responses.

Source 1DOIPubMed

It is positioned as a response to the immunosuppressive TME that impairs immune cell efficacy.

Source 2DOIPubMed

Alternatives

The abstract also lists multi-antigen targeting and next-generation safety measures.

Source 2DOIPubMed

Evidence Snippets

including nanoparticle-based tumor vaccines for antigen presentation, checkpoint modulation and gene silencing via nanocarriers, tumor microenvironment reprogramming
Evidence 1Source 1DOIPubMedprovenance
reprogramming of the TME
Evidence 2Source 2DOIPubMedprovenance
TME can be reprogrammed by using a range of NCs to regulate immunosuppressive factors and activate immunostimulatory cells.
Evidence 3Source 3DOIPubMedprovenance

Supporting Sources

Linked Claims

Claim 1strategy classificationsupports2026Source 1DOIPubMed

Emerging nano-immunotherapeutic strategies for metastatic colorectal cancer can be categorized into four major classes: nanoparticle-based tumor vaccines for antigen presentation, checkpoint modulation and gene silencing via nanocarriers, tumor microenvironment reprogramming, and controlled induction of immunogenic cell death.

Quoted textsource-backed
We then systematically categorize emerging nano-immunotherapeutic strategies into four major classes, including nanoparticle-based tumor vaccines for antigen presentation, checkpoint modulation and gene silencing via nanocarriers, tumor microenvironment reprogramming, and the controlled induction of immunogenic cell death.
Claim 2functional rolesupports2025Source 3DOIPubMed

The tumor microenvironment has a major role in malignancy and can mediate tumor survival, metastasis, immune evasion, and drug resistance.

Claim 3mechanismsupports2025Source 3DOIPubMed

Nanocarriers can reprogram the tumor microenvironment by regulating immunosuppressive factors and activating immunostimulatory cells.

Claim 4strategy summarysupports2025Source 2DOIPubMed

Innovative strategies proposed to address solid-tumor CAR-T challenges include multi-antigen targeting, tumor microenvironment reprogramming, and next-generation safety measures.

Claim 5therapeutic strategysupports2025Source 3DOIPubMed

Reprogramming or regulating the immunosuppressive tumor microenvironment can contribute to cancer therapy.